KLHDC7B, also known as Kelch Domain Containing 7B, is a protein encoded by the KLHDC7B gene in humans. The protein belongs to the Kelch repeat superfamily, which is characterized by a sequence motif known as the Kelch repeat. These repeats form a β-propeller structure that is often involved in protein-protein interactions. Kelch domain-containing proteins play diverse roles in cellular functions, such as cytoskeleton organization, cellular morphology, and signal transduction.The specific function of KLHDC7B remains relatively uncharacterized compared to other well-studied members of the Kelch family. However, its structural features suggest that it may be involved in similar biological processes or pathways. The β-propeller structure of the Kelch domain is known to mediate interactions with various cellular components, implicating a potential role for KLHDC7B in assembling protein complexes or facilitating communication within the cell.
Research into KLHDC7B and other Kelch proteins often involves studying their expression patterns across different tissues and developmental stages, identifying the proteins they interact with, and elucidating their roles in the context of cellular signaling pathways. Advanced techniques, such as yeast two-hybrid screening, co-immunoprecipitation, and mass spectrometry, are commonly employed to uncover the molecular partners and biological functions of Kelch proteins.Understanding the role of KLHDC7B could provide insights into the regulation of the cytoskeleton, cell adhesion, and other cellular processes that rely on protein scaffolding and signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor, potentially affecting ubiquitin-mediated protein degradation pathways involving KLHDC7B. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Another proteasome inhibitor, might impact protein degradation pathways relevant to KLHDC7B. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
A selective proteasome inhibitor, could influence KLHDC7B-related processes. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates the ubiquitin-proteasome system, potentially affecting KLHDC7B's role in protein ubiquitination. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Influences multiple signaling pathways, potentially impacting KLHDC7B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, might influence cellular processes relevant to KLHDC7B's function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling, potentially intersecting with pathways involving KLHDC7B. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, can impact gene expression and potentially KLHDC7B function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Alters DNA methylation, potentially impacting gene expression patterns relevant to KLHDC7B. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Influences histone acetylation, potentially affecting the expression of genes like KLHDC7B. | ||||||